Lv1
74 积分 2024-08-07 加入
Structural basis of inhibition of the human SGLT2–MAP17 glucose transporter
7小时前
已完结
Type 2 Diabetes Mellitus in Children and Adolescents: Early Prevention and Non-Drug Therapy
11小时前
已完结
Current insights and emerging trends in early-onset type 2 diabetes
3天前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
4天前
已关闭
Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
5天前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
5天前
已关闭
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
6天前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
6天前
已完结
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial
6天前
已完结
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
6天前
已关闭
白光内镜下结直肠肿瘤性质预测模型的构建与验证
18天前
已采纳
2012年中国成人社区获得性呼吸道感染主要致病菌耐药性的多中心研究
18天前
已采纳
读“糖皮质激素类药物临床应用指导原则”一文体会
18天前
已采纳
巨淀粉酶血症的研究进展
18天前
已采纳
皖公网安备34019202002308
